Historical record - last NADAC effective date: 1/22/2014
Product Information
CEFAZOLIN 10 GM VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $7.2930 per EA under NDC 63323023861. Its NADAC has been published 5 times since Jan 22, 2014.
FDA first approved this application on Oct 22, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 g/1
Manufacturer
Fresenius Kabi USA, LLCNDC
63323023861
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
1/22/2014
Active Ingredients
CEFAZOLIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065306FDA Approved
10/22/2008
TE Code
AP
On Market Since
6/14/2011
Pharmacological Classes
Price Statistics
The NADAC for CEFAZOLIN 10 GM VIAL has been published 5 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.2930 per EA |
|---|---|
| All-time high | $7.2930 (Feb 19, 2014) |
| All-time low | $7.2930 (Jan 22, 2014) |
| Median price | $7.2930 |
| Average price | $7.2930 |
| Largest weekly change | 0.0% (Jan 29, 2014) |
| Weeks tracked | 5 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Feb 19, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cefazolin Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefazolin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFAZOLIN 10 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFAZOLIN 10 GM VIAL, manufactured by Fresenius Kabi USA, LLC, is $7.2930 per EA (NDC 63323023861), effective Feb 19, 2014.
How has the price of CEFAZOLIN 10 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFAZOLIN 10 GM VIAL has held within roughly two percent of its current level. It has been tracked across 5 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CEFAZOLIN 10 GM VIAL?
Since Jan 22, 2014, the NADAC for CEFAZOLIN 10 GM VIAL has ranged from a low of $7.2930 (Jan 22, 2014) to a high of $7.2930 (Feb 19, 2014), with a median of $7.2930 per EA.
Are there cheaper alternatives to CEFAZOLIN 10 GM VIAL?
No other NADAC-published product currently shares the active ingredient and strength of CEFAZOLIN 10 GM VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEFAZOLIN 10 GM VIAL?
CEFAZOLIN 10 GM VIAL (NDC 63323023861) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.